Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.
Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC. Muller AJ, et al. Among authors: sutanto ward e. Nat Med. 2005 Mar;11(3):312-9. doi: 10.1038/nm1196. Epub 2005 Feb 13. Nat Med. 2005. PMID: 15711557
Targeted deletion of the suppressor gene bin1/amphiphysin2 accentuates the neoplastic character of transformed mouse fibroblasts.
Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC. Muller AJ, et al. Among authors: sutanto ward e. Cancer Biol Ther. 2004 Dec;3(12):1236-42. doi: 10.4161/cbt.3.12.1232. Epub 2004 Dec 14. Cancer Biol Ther. 2004. PMID: 15611650
Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression.
Chang MY, Boulden J, Sutanto-Ward E, Duhadaway JB, Soler AP, Muller AJ, Prendergast GC. Chang MY, et al. Among authors: sutanto ward e. Cancer Res. 2007 Jan 1;67(1):100-7. doi: 10.1158/0008-5472.CAN-06-2742. Cancer Res. 2007. PMID: 17210688 Free article.
A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.
Banerjee T, Duhadaway JB, Gaspari P, Sutanto-Ward E, Munn DH, Mellor AL, Malachowski WP, Prendergast GC, Muller AJ. Banerjee T, et al. Among authors: sutanto ward e. Oncogene. 2008 May 1;27(20):2851-7. doi: 10.1038/sj.onc.1210939. Epub 2007 Nov 19. Oncogene. 2008. PMID: 18026137 Free article.
Bin3 deletion causes cataracts and increased susceptibility to lymphoma during aging.
Ramalingam A, Duhadaway JB, Sutanto-Ward E, Wang Y, Dinchuk J, Huang M, Donover PS, Boulden J, McNally LM, Soler AP, Muller AJ, Duncan MK, Prendergast GC. Ramalingam A, et al. Among authors: sutanto ward e. Cancer Res. 2008 Mar 15;68(6):1683-90. doi: 10.1158/0008-5472.CAN-07-6072. Cancer Res. 2008. PMID: 18339847 Free article.
Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion.
Muller AJ, DuHadaway JB, Chang MY, Ramalingam A, Sutanto-Ward E, Boulden J, Soler AP, Mandik-Nayak L, Gilmour SK, Prendergast GC. Muller AJ, et al. Among authors: sutanto ward e. Cancer Immunol Immunother. 2010 Nov;59(11):1655-63. doi: 10.1007/s00262-010-0891-4. Epub 2010 Jul 17. Cancer Immunol Immunother. 2010. PMID: 20640572 Free PMC article.
IDO is a nodal pathogenic driver of lung cancer and metastasis development.
Smith C, Chang MY, Parker KH, Beury DW, DuHadaway JB, Flick HE, Boulden J, Sutanto-Ward E, Soler AP, Laury-Kleintop LD, Mandik-Nayak L, Metz R, Ostrand-Rosenberg S, Prendergast GC, Muller AJ. Smith C, et al. Among authors: sutanto ward e. Cancer Discov. 2012 Aug;2(8):722-35. doi: 10.1158/2159-8290.CD-12-0014. Epub 2012 Jul 19. Cancer Discov. 2012. PMID: 22822050 Free PMC article.
IDO1 is an Integral Mediator of Inflammatory Neovascularization.
Mondal A, Smith C, DuHadaway JB, Sutanto-Ward E, Prendergast GC, Bravo-Nuevo A, Muller AJ. Mondal A, et al. Among authors: sutanto ward e. EBioMedicine. 2016 Dec;14:74-82. doi: 10.1016/j.ebiom.2016.11.013. Epub 2016 Nov 9. EBioMedicine. 2016. PMID: 27889479 Free PMC article.
Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses.
Dey S, Sutanto-Ward E, Kopp KL, DuHadaway J, Mondal A, Ghaban D, Lecoq I, Zocca MB, Merlo LMF, Mandik-Nayak L, Andersen MH, Pedersen AW, Muller AJ. Dey S, et al. Among authors: sutanto ward e. J Immunother Cancer. 2020 Jul;8(2):e000605. doi: 10.1136/jitc-2020-000605. J Immunother Cancer. 2020. PMID: 32690770 Free PMC article.
Host IDO2 Gene Status Influences Tumor Progression and Radiotherapy Response in KRAS-Driven Sporadic Pancreatic Cancers.
Nevler A, Muller AJ, Sutanto-Ward E, DuHadaway JB, Nagatomo K, Londin E, O'Hayer K, Cozzitorto JA, Lavu H, Yeo TP, Curtis M, Villatoro T, Leiby BE, Mandik-Nayak L, Winter JM, Yeo CJ, Prendergast GC, Brody JR. Nevler A, et al. Among authors: sutanto ward e. Clin Cancer Res. 2019 Jan 15;25(2):724-734. doi: 10.1158/1078-0432.CCR-18-0814. Epub 2018 Sep 28. Clin Cancer Res. 2019. PMID: 30266763 Free PMC article.
17 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback